SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-030429
Filing Date
2015-02-03
Accepted
2015-02-03 08:04:33
Documents
4
Period of Report
2015-01-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d864040d8k.htm 8-K 22810
2 EX-10.1 d864040dex101.htm EX-10.1 19320
3 EX-99.1 d864040dex991.htm EX-99.1 7732
4 GRAPHIC g864040ex99_1pg01.jpg GRAPHIC 3362
  Complete submission text file 0001193125-15-030429.txt   55925
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 15569132
SIC: 2834 Pharmaceutical Preparations